Age-related Macular Degeneration Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Age-related Macular Degeneration Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Wet AMD
1.2.3 Dry AMD
1.3 Market by Application
1.3.1 Global Age-related Macular Degeneration Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Drugstore
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Age-related Macular Degeneration Market Perspective (2017-2028)
2.2 Age-related Macular Degeneration Growth Trends by Region
2.2.1 Age-related Macular Degeneration Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Age-related Macular Degeneration Historic Market Size by Region (2017-2022)
2.2.3 Age-related Macular Degeneration Forecasted Market Size by Region (2023-2028)
2.3 Age-related Macular Degeneration Market Dynamics
2.3.1 Age-related Macular Degeneration Industry Trends
2.3.2 Age-related Macular Degeneration Market Drivers
2.3.3 Age-related Macular Degeneration Market Challenges
2.3.4 Age-related Macular Degeneration Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Age-related Macular Degeneration Players by Revenue
3.1.1 Global Top Age-related Macular Degeneration Players by Revenue (2017-2022)
3.1.2 Global Age-related Macular Degeneration Revenue Market Share by Players (2017-2022)
3.2 Global Age-related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Age-related Macular Degeneration Revenue
3.4 Global Age-related Macular Degeneration Market Concentration Ratio
3.4.1 Global Age-related Macular Degeneration Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Age-related Macular Degeneration Revenue in 2021
3.5 Age-related Macular Degeneration Key Players Head office and Area Served
3.6 Key Players Age-related Macular Degeneration Product Solution and Service
3.7 Date of Enter into Age-related Macular Degeneration Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Age-related Macular Degeneration Breakdown Data by Type
4.1 Global Age-related Macular Degeneration Historic Market Size by Type (2017-2022)
4.2 Global Age-related Macular Degeneration Forecasted Market Size by Type (2023-2028)
5 Age-related Macular Degeneration Breakdown Data by Application
5.1 Global Age-related Macular Degeneration Historic Market Size by Application (2017-2022)
5.2 Global Age-related Macular Degeneration Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Age-related Macular Degeneration Market Size (2017-2028)
6.2 North America Age-related Macular Degeneration Market Size by Type
6.2.1 North America Age-related Macular Degeneration Market Size by Type (2017-2022)
6.2.2 North America Age-related Macular Degeneration Market Size by Type (2023-2028)
6.2.3 North America Age-related Macular Degeneration Market Share by Type (2017-2028)
6.3 North America Age-related Macular Degeneration Market Size by Application
6.3.1 North America Age-related Macular Degeneration Market Size by Application (2017-2022)
6.3.2 North America Age-related Macular Degeneration Market Size by Application (2023-2028)
6.3.3 North America Age-related Macular Degeneration Market Share by Application (2017-2028)
6.4 North America Age-related Macular Degeneration Market Size by Country
6.4.1 North America Age-related Macular Degeneration Market Size by Country (2017-2022)
6.4.2 North America Age-related Macular Degeneration Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Age-related Macular Degeneration Market Size (2017-2028)
7.2 Europe Age-related Macular Degeneration Market Size by Type
7.2.1 Europe Age-related Macular Degeneration Market Size by Type (2017-2022)
7.2.2 Europe Age-related Macular Degeneration Market Size by Type (2023-2028)
7.2.3 Europe Age-related Macular Degeneration Market Share by Type (2017-2028)
7.3 Europe Age-related Macular Degeneration Market Size by Application
7.3.1 Europe Age-related Macular Degeneration Market Size by Application (2017-2022)
7.3.2 Europe Age-related Macular Degeneration Market Size by Application (2023-2028)
7.3.3 Europe Age-related Macular Degeneration Market Share by Application (2017-2028)
7.4 Europe Age-related Macular Degeneration Market Size by Country
7.4.1 Europe Age-related Macular Degeneration Market Size by Country (2017-2022)
7.4.2 Europe Age-related Macular Degeneration Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Age-related Macular Degeneration Market Size (2017-2028)
8.2 Asia-Pacific Age-related Macular Degeneration Market Size by Type
8.2.1 Asia-Pacific Age-related Macular Degeneration Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Age-related Macular Degeneration Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Age-related Macular Degeneration Market Share by Type (2017-2028)
8.3 Asia-Pacific Age-related Macular Degeneration Market Size by Application
8.3.1 Asia-Pacific Age-related Macular Degeneration Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Age-related Macular Degeneration Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Age-related Macular Degeneration Market Share by Application (2017-2028)
8.4 Asia-Pacific Age-related Macular Degeneration Market Size by Region
8.4.1 Asia-Pacific Age-related Macular Degeneration Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Age-related Macular Degeneration Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Age-related Macular Degeneration Market Size (2017-2028)
9.2 Latin America Age-related Macular Degeneration Market Size by Type
9.2.1 Latin America Age-related Macular Degeneration Market Size by Type (2017-2022)
9.2.2 Latin America Age-related Macular Degeneration Market Size by Type (2023-2028)
9.2.3 Latin America Age-related Macular Degeneration Market Share by Type (2017-2028)
9.3 Latin America Age-related Macular Degeneration Market Size by Application
9.3.1 Latin America Age-related Macular Degeneration Market Size by Application (2017-2022)
9.3.2 Latin America Age-related Macular Degeneration Market Size by Application (2023-2028)
9.3.3 Latin America Age-related Macular Degeneration Market Share by Application (2017-2028)
9.4 Latin America Age-related Macular Degeneration Market Size by Country
9.4.1 Latin America Age-related Macular Degeneration Market Size by Country (2017-2022)
9.4.2 Latin America Age-related Macular Degeneration Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Age-related Macular Degeneration Market Size (2017-2028)
10.2 Middle East & Africa Age-related Macular Degeneration Market Size by Type
10.2.1 Middle East & Africa Age-related Macular Degeneration Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Age-related Macular Degeneration Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Age-related Macular Degeneration Market Share by Type (2017-2028)
10.3 Middle East & Africa Age-related Macular Degeneration Market Size by Application
10.3.1 Middle East & Africa Age-related Macular Degeneration Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Age-related Macular Degeneration Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Age-related Macular Degeneration Market Share by Application (2017-2028)
10.4 Middle East & Africa Age-related Macular Degeneration Market Size by Country
10.4.1 Middle East & Africa Age-related Macular Degeneration Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Age-related Macular Degeneration Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer HealthCare
11.1.1 Bayer HealthCare Company Details
11.1.2 Bayer HealthCare Business Overview
11.1.3 Bayer HealthCare Age-related Macular Degeneration Introduction
11.1.4 Bayer HealthCare Revenue in Age-related Macular Degeneration Business (2017-2022)
11.1.5 Bayer HealthCare Recent Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Age-related Macular Degeneration Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Age-related Macular Degeneration Business (2017-2022)
11.2.5 F. Hoffmann-La Roche Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Age-related Macular Degeneration Introduction
11.3.4 Novartis Revenue in Age-related Macular Degeneration Business (2017-2022)
11.3.5 Novartis Recent Developments
11.4 Regeneron Pharmaceuticals
11.4.1 Regeneron Pharmaceuticals Company Details
11.4.2 Regeneron Pharmaceuticals Business Overview
11.4.3 Regeneron Pharmaceuticals Age-related Macular Degeneration Introduction
11.4.4 Regeneron Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2017-2022)
11.4.5 Regeneron Pharmaceuticals Recent Developments
11.5 Alcon
11.5.1 Alcon Company Details
11.5.2 Alcon Business Overview
11.5.3 Alcon Age-related Macular Degeneration Introduction
11.5.4 Alcon Revenue in Age-related Macular Degeneration Business (2017-2022)
11.5.5 Alcon Recent Developments
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Allergan Business Overview
11.6.3 Allergan Age-related Macular Degeneration Introduction
11.6.4 Allergan Revenue in Age-related Macular Degeneration Business (2017-2022)
11.6.5 Allergan Recent Developments
11.7 Avalanche
11.7.1 Avalanche Company Details
11.7.2 Avalanche Business Overview
11.7.3 Avalanche Age-related Macular Degeneration Introduction
11.7.4 Avalanche Revenue in Age-related Macular Degeneration Business (2017-2022)
11.7.5 Avalanche Recent Developments
11.8 Bausch+Lomb
11.8.1 Bausch+Lomb Company Details
11.8.2 Bausch+Lomb Business Overview
11.8.3 Bausch+Lomb Age-related Macular Degeneration Introduction
11.8.4 Bausch+Lomb Revenue in Age-related Macular Degeneration Business (2017-2022)
11.8.5 Bausch+Lomb Recent Developments
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Details
11.9.2 Gilead Sciences Business Overview
11.9.3 Gilead Sciences Age-related Macular Degeneration Introduction
11.9.4 Gilead Sciences Revenue in Age-related Macular Degeneration Business (2017-2022)
11.9.5 Gilead Sciences Recent Developments
11.10 Iconic Therapeutics
11.10.1 Iconic Therapeutics Company Details
11.10.2 Iconic Therapeutics Business Overview
11.10.3 Iconic Therapeutics Age-related Macular Degeneration Introduction
11.10.4 Iconic Therapeutics Revenue in Age-related Macular Degeneration Business (2017-2022)
11.10.5 Iconic Therapeutics Recent Developments
11.11 Neurotech Pharmaceuticals
11.11.1 Neurotech Pharmaceuticals Company Details
11.11.2 Neurotech Pharmaceuticals Business Overview
11.11.3 Neurotech Pharmaceuticals Age-related Macular Degeneration Introduction
11.11.4 Neurotech Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2017-2022)
11.11.5 Neurotech Pharmaceuticals Recent Developments
11.12 Ohr Pharmaceutical
11.12.1 Ohr Pharmaceutical Company Details
11.12.2 Ohr Pharmaceutical Business Overview
11.12.3 Ohr Pharmaceutical Age-related Macular Degeneration Introduction
11.12.4 Ohr Pharmaceutical Revenue in Age-related Macular Degeneration Business (2017-2022)
11.12.5 Ohr Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Age-related Macular Degeneration Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Wet AMD
Table 3. Key Players of Dry AMD
Table 4. Global Age-related Macular Degeneration Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Age-related Macular Degeneration Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Age-related Macular Degeneration Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Age-related Macular Degeneration Market Share by Region (2017-2022)
Table 8. Global Age-related Macular Degeneration Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Age-related Macular Degeneration Market Share by Region (2023-2028)
Table 10. Age-related Macular Degeneration Market Trends
Table 11. Age-related Macular Degeneration Market Drivers
Table 12. Age-related Macular Degeneration Market Challenges
Table 13. Age-related Macular Degeneration Market Restraints
Table 14. Global Age-related Macular Degeneration Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Age-related Macular Degeneration Revenue Share by Players (2017-2022)
Table 16. Global Top Age-related Macular Degeneration by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-related Macular Degeneration as of 2021)
Table 17. Ranking of Global Top Age-related Macular Degeneration Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Age-related Macular Degeneration Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Age-related Macular Degeneration Product Solution and Service
Table 21. Date of Enter into Age-related Macular Degeneration Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Age-related Macular Degeneration Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Age-related Macular Degeneration Revenue Market Share by Type (2017-2022)
Table 25. Global Age-related Macular Degeneration Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Age-related Macular Degeneration Revenue Market Share by Type (2023-2028)
Table 27. Global Age-related Macular Degeneration Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Age-related Macular Degeneration Revenue Share by Application (2017-2022)
Table 29. Global Age-related Macular Degeneration Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Age-related Macular Degeneration Revenue Share by Application (2023-2028)
Table 31. North America Age-related Macular Degeneration Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Age-related Macular Degeneration Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Age-related Macular Degeneration Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Age-related Macular Degeneration Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Age-related Macular Degeneration Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Age-related Macular Degeneration Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Age-related Macular Degeneration Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Age-related Macular Degeneration Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Age-related Macular Degeneration Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Age-related Macular Degeneration Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Age-related Macular Degeneration Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Age-related Macular Degeneration Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Age-related Macular Degeneration Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Age-related Macular Degeneration Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Age-related Macular Degeneration Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Age-related Macular Degeneration Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Age-related Macular Degeneration Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Age-related Macular Degeneration Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Age-related Macular Degeneration Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Age-related Macular Degeneration Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Age-related Macular Degeneration Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Age-related Macular Degeneration Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Age-related Macular Degeneration Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Age-related Macular Degeneration Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Age-related Macular Degeneration Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Age-related Macular Degeneration Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Age-related Macular Degeneration Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Age-related Macular Degeneration Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Age-related Macular Degeneration Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Age-related Macular Degeneration Market Size by Country (2023-2028) & (US$ Million)
Table 61. Bayer HealthCare Company Details
Table 62. Bayer HealthCare Business Overview
Table 63. Bayer HealthCare Age-related Macular Degeneration Product
Table 64. Bayer HealthCare Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 65. Bayer HealthCare Recent Developments
Table 66. F. Hoffmann-La Roche Company Details
Table 67. F. Hoffmann-La Roche Business Overview
Table 68. F. Hoffmann-La Roche Age-related Macular Degeneration Product
Table 69. F. Hoffmann-La Roche Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 70. F. Hoffmann-La Roche Recent Developments
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Age-related Macular Degeneration Product
Table 74. Novartis Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 75. Novartis Recent Developments
Table 76. Regeneron Pharmaceuticals Company Details
Table 77. Regeneron Pharmaceuticals Business Overview
Table 78. Regeneron Pharmaceuticals Age-related Macular Degeneration Product
Table 79. Regeneron Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 80. Regeneron Pharmaceuticals Recent Developments
Table 81. Alcon Company Details
Table 82. Alcon Business Overview
Table 83. Alcon Age-related Macular Degeneration Product
Table 84. Alcon Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 85. Alcon Recent Developments
Table 86. Allergan Company Details
Table 87. Allergan Business Overview
Table 88. Allergan Age-related Macular Degeneration Product
Table 89. Allergan Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 90. Allergan Recent Developments
Table 91. Avalanche Company Details
Table 92. Avalanche Business Overview
Table 93. Avalanche Age-related Macular Degeneration Product
Table 94. Avalanche Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 95. Avalanche Recent Developments
Table 96. Bausch+Lomb Company Details
Table 97. Bausch+Lomb Business Overview
Table 98. Bausch+Lomb Age-related Macular Degeneration Product
Table 99. Bausch+Lomb Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 100. Bausch+Lomb Recent Developments
Table 101. Gilead Sciences Company Details
Table 102. Gilead Sciences Business Overview
Table 103. Gilead Sciences Age-related Macular Degeneration Product
Table 104. Gilead Sciences Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 105. Gilead Sciences Recent Developments
Table 106. Iconic Therapeutics Company Details
Table 107. Iconic Therapeutics Business Overview
Table 108. Iconic Therapeutics Age-related Macular Degeneration Product
Table 109. Iconic Therapeutics Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 110. Iconic Therapeutics Recent Developments
Table 111. Neurotech Pharmaceuticals Company Details
Table 112. Neurotech Pharmaceuticals Business Overview
Table 113. Neurotech Pharmaceuticals Age-related Macular Degeneration Product
Table 114. Neurotech Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 115. Neurotech Pharmaceuticals Recent Developments
Table 116. Ohr Pharmaceutical Company Details
Table 117. Ohr Pharmaceutical Business Overview
Table 118. Ohr Pharmaceutical Age-related Macular Degeneration Product
Table 119. Ohr Pharmaceutical Revenue in Age-related Macular Degeneration Business (2017-2022) & (US$ Million)
Table 120. Ohr Pharmaceutical Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Age-related Macular Degeneration Market Share by Type: 2021 VS 2028
Figure 2. Wet AMD Features
Figure 3. Dry AMD Features
Figure 4. Global Age-related Macular Degeneration Market Share by Application: 2021 VS 2028
Figure 5. Drugstore Case Studies
Figure 6. Hospital Case Studies
Figure 7. Others Case Studies
Figure 8. Age-related Macular Degeneration Report Years Considered
Figure 9. Global Age-related Macular Degeneration Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Age-related Macular Degeneration Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Age-related Macular Degeneration Market Share by Region: 2021 VS 2028
Figure 12. Global Age-related Macular Degeneration Market Share by Players in 2021
Figure 13. Global Top Age-related Macular Degeneration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-related Macular Degeneration as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Age-related Macular Degeneration Revenue in 2021
Figure 15. North America Age-related Macular Degeneration Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Age-related Macular Degeneration Market Size Market Share by Type (2017-2028)
Figure 17. North America Age-related Macular Degeneration Market Size Market Share by Application (2017-2028)
Figure 18. North America Age-related Macular Degeneration Market Size Share by Country (2017-2028)
Figure 19. United States Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Age-related Macular Degeneration Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Age-related Macular Degeneration Market Size Market Share by Type (2017-2028)
Figure 23. Europe Age-related Macular Degeneration Market Size Market Share by Application (2017-2028)
Figure 24. Europe Age-related Macular Degeneration Market Size Share by Country (2017-2028)
Figure 25. Germany Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Age-related Macular Degeneration Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Age-related Macular Degeneration Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Age-related Macular Degeneration Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Age-related Macular Degeneration Market Size Share by Region (2017-2028)
Figure 35. China Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Age-related Macular Degeneration Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Age-related Macular Degeneration Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Age-related Macular Degeneration Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Age-related Macular Degeneration Market Size Share by Country (2017-2028)
Figure 45. Mexico Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Age-related Macular Degeneration Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Age-related Macular Degeneration Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Age-related Macular Degeneration Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Age-related Macular Degeneration Market Size Share by Country (2017-2028)
Figure 51. Turkey Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Age-related Macular Degeneration Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Bayer HealthCare Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 55. F. Hoffmann-La Roche Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 56. Novartis Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 57. Regeneron Pharmaceuticals Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 58. Alcon Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 59. Allergan Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 60. Avalanche Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 61. Bausch+Lomb Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 62. Gilead Sciences Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 63. Iconic Therapeutics Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 64. Neurotech Pharmaceuticals Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 65. Ohr Pharmaceutical Revenue Growth Rate in Age-related Macular Degeneration Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Industry Market Size
